Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Clinical trial NCT00946946 · COMPLETED

Trial details

NCT number: NCT00946946
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-02-01
Primary completion: 2007-05-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.